Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Results of AVI-4126 in PKD patients

Feb. 28, 2003

New PDE5 inhibitors in early development at Tanabe Seiyaku

Feb. 20, 2003

YC-1 increases the incidence of penile erection in rats

Feb. 18, 2003

New PDE5 inhibitors identified by Lilly Icos team

Feb. 6, 2003

Ferring researchers identify new oxytocin agonists

Feb. 6, 2003

Pfizer claims new 5-HT2C receptor modulators and their use in sexual disorders

Feb. 6, 2003

Cialis now available for prescription in several markets

Feb. 5, 2003

GenoMed evaluates intravenous drug regimen for acute kidney failure

Feb. 3, 2003

Second filing announced for YM-905

Jan. 30, 2003

Kissei presents potent and selective beta3-adrenoceptor agonists for bladder dysfunction

Jan. 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....